Dr. Blakeley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 North Caroline Street
Baltimore, MD 21287Phone+1 410-955-9441Fax+1 410-955-6402
Summary
- Dr. Jaishri Blakeley is a neurologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. She received her medical degree from Baylor College of Medicine and has been in practice 16 years. She specializes in neurooncology and is experienced in neurofibromatosis, neuro-oncology, gliomas, drug delivery systems, and clinical trials.
Education & Training
- Johns Hopkins UniversityResidency, Neurology, 2002 - 2005
- Baylor College of MedicineInternship, Internal Medicine, 2001 - 2002
- Baylor College of MedicineClass of 2001
Certifications & Licensure
- FL State Medical License 2023 - Present
- MD State Medical License 2006 - 2026
- NC State Medical License 2020 - 2022
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma Start of enrollment: 2008 Jan 01
- Concentration and Activity of Lapatinib in Vestibular Schwannomas Start of enrollment: 2009 Jun 01
- Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2010 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsEarly phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas.D. Bradley Welling, Katharine Collier, Sarah S. Burns, Janet L. Oblinger, Edina Shu
Laryngoscope Investigative Otolaryngology. 2021-08-20 - 18 citationsLong-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.Andrea M Gross, Eva Dombi, Pamela L Wolters, Andrea Baldwin, Anne Dufek
Neuro-Oncology. 2023-10-03 - 20 citationsConsiderations for development of therapies for cutaneous neurofibromaSharad K. Verma, Vincent M. Riccardi, Scott R. Plotkin, Hubert Weinberg, R. Rox Anderson
Neurology. 2018-07-10
Press Mentions
- Bringing Brigatinib to Neurofibromatosis Type-2 Patients: From Promising Potential to Platform Clinical TrialMay 29th, 2020
- Health Beat: NF Tumors: Hearing Can Be RestoredSeptember 21st, 2016
- Anticancer Drug Restores Hearing in Some Patients with NeurofibromatosisMarch 14th, 2016
Professional Memberships
- Member
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/jaishri-blakeley
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: